369 related articles for article (PubMed ID: 12228882)
1. A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials.
Baujat B; Mahé C; Pignon JP; Hill C
Stat Med; 2002 Sep; 21(18):2641-52. PubMed ID: 12228882
[TBL] [Abstract][Full Text] [Related]
2. Random effects survival models gave a better understanding of heterogeneity in individual patient data meta-analyses.
Michiels S; Baujat B; Mahé C; Sargent DJ; Pignon JP
J Clin Epidemiol; 2005 Mar; 58(3):238-45. PubMed ID: 15718112
[TBL] [Abstract][Full Text] [Related]
3. Investigating trial and treatment heterogeneity in an individual patient data meta-analysis of survival data by means of the penalized maximum likelihood approach.
Rondeau V; Michiels S; Liquet B; Pignon JP
Stat Med; 2008 May; 27(11):1894-910. PubMed ID: 18069745
[TBL] [Abstract][Full Text] [Related]
4. Exploring heterogeneity in meta-analyses: needs, resources and challenges.
Xu H; Platt RW; Luo ZC; Wei S; Fraser WD
Paediatr Perinat Epidemiol; 2008 Jan; 22 Suppl 1():18-28. PubMed ID: 18237348
[TBL] [Abstract][Full Text] [Related]
5. How should meta-regression analyses be undertaken and interpreted?
Thompson SG; Higgins JP
Stat Med; 2002 Jun; 21(11):1559-73. PubMed ID: 12111920
[TBL] [Abstract][Full Text] [Related]
6. A non-parametric procedure for evaluating treatment effect in the meta-analysis of survival data.
Moodie PF; Nelson NA; Koch GG
Stat Med; 2004 Apr; 23(7):1075-93. PubMed ID: 15057879
[TBL] [Abstract][Full Text] [Related]
7. [Application of Meta-regression and subgroup analyses of heterogeneity disposal in Meta-analysis].
Shi XQ; Wang ZZ
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 May; 29(5):497-501. PubMed ID: 18956686
[TBL] [Abstract][Full Text] [Related]
8. Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research.
Sterne JA; Jüni P; Schulz KF; Altman DG; Bartlett C; Egger M
Stat Med; 2002 Jun; 21(11):1513-24. PubMed ID: 12111917
[TBL] [Abstract][Full Text] [Related]
9. [Application of Stata software to test heterogeneity in meta-analysis method].
Wang D; Mou ZY; Zhai JX; Zong HX; Zhao XD
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jul; 29(7):726-9. PubMed ID: 19031771
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis combining parallel and cross-over clinical trials. III: The issue of carry-over.
Curtin F; Elbourne D; Altman DG
Stat Med; 2002 Aug; 21(15):2161-73. PubMed ID: 12210631
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of cancer trials: a new approach to the assessment of treatment.
A'Hern RP; Ebbs S
Anticancer Res; 1987; 7(5B):955-8. PubMed ID: 3324939
[TBL] [Abstract][Full Text] [Related]
12. Individual patients' data meta-analyses in head and neck cancer.
Bourhis J; Le Maître A; Baujat B; Audry H; Pignon JP; ; ;
Curr Opin Oncol; 2007 May; 19(3):188-94. PubMed ID: 17414635
[TBL] [Abstract][Full Text] [Related]
13. Understanding the results of meta-analyses in the treatment of head and neck squamous cell cancer.
Hotte SJ; Wright JR
Hematol Oncol Clin North Am; 2008 Dec; 22(6):1257-66, x. PubMed ID: 19010272
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
Budach W; Hehr T; Budach V; Belka C; Dietz K
BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
[TBL] [Abstract][Full Text] [Related]
15. Individual patient-level and study-level meta-analysis for investigating modifiers of treatment effect.
Teramukai S; Matsuyama Y; Mizuno S; Sakamoto J
Jpn J Clin Oncol; 2004 Dec; 34(12):717-21. PubMed ID: 15640501
[TBL] [Abstract][Full Text] [Related]
16. [Meta-analysis as a tool for gaining knowledge].
Koch A; Ziegler S
Med Klin (Munich); 2000 May; 95(1 Spec No):83-90. PubMed ID: 10851854
[TBL] [Abstract][Full Text] [Related]
17. Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes.
Smith CT; Williamson PR; Marson AG
Stat Med; 2005 May; 24(9):1307-19. PubMed ID: 15685717
[TBL] [Abstract][Full Text] [Related]
18. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
[TBL] [Abstract][Full Text] [Related]
19. Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials.
Mozaffarian D; Geelen A; Brouwer IA; Geleijnse JM; Zock PL; Katan MB
Circulation; 2005 Sep; 112(13):1945-52. PubMed ID: 16172267
[TBL] [Abstract][Full Text] [Related]
20. Investigating patient exclusion bias in meta-analysis.
Tierney JF; Stewart LA
Int J Epidemiol; 2005 Feb; 34(1):79-87. PubMed ID: 15561753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
